LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro

J Jacob Wamsley1, Natalia Issaeva1,2, Hanbing An3

  • 1a Department of Surgery, Division of Otolaryngology , Yale University , New Haven , CT , USA.

Insights

LZAP protein binds and enhances the phosphatase activity of Wip1, a key regulator of the DNA damage response. This interaction potentiates Wip1

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Biochemistry

Background:

  • The phosphatase Wip1 regulates the DNA damage response (DDR) by dephosphorylating key proteins like p53 and MDM2.
  • LZAP, a potential tumor suppressor, interacts with several Wip1 substrates but lacks catalytic activity.
  • LZAP's mechanism of action suggests it functions via protein-protein interactions.

Purpose of the Study:

  • To investigate the interaction between LZAP and Wip1.
  • To determine if LZAP modulates Wip1 phosphatase activity.
  • To identify novel Wip1 and LZAP substrates and binding partners.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • In vitro phosphatase assays using full-length proteins and phosphopeptides.
  • Mass spectrometry or western blotting to identify and validate substrates.

Main Results:

  • LZAP directly binds to Wip1 and significantly stimulates its phosphatase activity.
  • LZAP potentiates Wip1-mediated dephosphorylation of known substrates (RelA, p38, Chk1/2, MDM2) and novel substrates (ERK1, HuR).
  • HuR is identified as a novel binding partner of LZAP.
  • LZAP's augmentation of Wip1 activity does not require direct binding to the substrate.

Conclusions:

  • LZAP acts as a positive regulator of Wip1 phosphatase activity.
  • LZAP enhances Wip1's role in attenuating the DNA damage response and potentially other cellular processes.
  • The findings reveal a novel mechanism for regulating phosphatase activity through protein complex formation.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.4K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.4K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K